Pharmaceutical composition comprising a p2x7-receptor antagonist and a tumour necrosis factor alpha
The invention provides a pharmaceutical product or kit comprising a first active ingredient which is a P2X7 receptor antagonist which P2X7 receptor antagonist is an adamantyl derivative and a second active ingredient which is a tumour necrosis factor alpha (TNFalpha) inhibitor, for use in the treatm...
Saved in:
Main Author | |
---|---|
Format | Patent |
Language | English |
Published |
08.02.2007
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention provides a pharmaceutical product or kit comprising a first active ingredient which is a P2X7 receptor antagonist which P2X7 receptor antagonist is an adamantyl derivative and a second active ingredient which is a tumour necrosis factor alpha (TNFalpha) inhibitor, for use in the treatment of inflammatory disorders. |
---|---|
Bibliography: | Application Number: US20040558354 |